VANI vs. SMTI, LUNG, DRTS, ELMD, ZYXI, INGN, NYXH, RCEL, CATX, and PROF
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Sanara MedTech (SMTI), Pulmonx (LUNG), Alpha Tau Medical (DRTS), Electromed (ELMD), Zynex (ZYXI), Inogen (INGN), Nyxoah (NYXH), AVITA Medical (RCEL), Perspective Therapeutics (CATX), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.
Vivani Medical vs.
Sanara MedTech (NASDAQ:SMTI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, community ranking, risk, media sentiment, profitability and institutional ownership.
Sanara MedTech presently has a consensus price target of $47.00, suggesting a potential upside of 44.00%. Vivani Medical has a consensus price target of $3.00, suggesting a potential upside of 150.00%. Given Vivani Medical's higher probable upside, analysts plainly believe Vivani Medical is more favorable than Sanara MedTech.
Sanara MedTech has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.23, indicating that its share price is 223% more volatile than the S&P 500.
Sanara MedTech has higher revenue and earnings than Vivani Medical. Sanara MedTech is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.
Sanara MedTech received 17 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 55.88% of users gave Sanara MedTech an outperform vote.
Vivani Medical has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Vivani Medical's return on equity.
8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by insiders. Comparatively, 44.3% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, Vivani Medical had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 1 mentions for Vivani Medical and 0 mentions for Sanara MedTech. Vivani Medical's average media sentiment score of 1.46 beat Sanara MedTech's score of 0.50 indicating that Vivani Medical is being referred to more favorably in the news media.
Summary
Sanara MedTech and Vivani Medical tied by winning 8 of the 16 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
This page (NASDAQ:VANI) was last updated on 1/21/2025 by MarketBeat.com Staff
Free VANI Stock Alerts